January, 2018 - Microbiome Times Magazine

BiomX Licenses Novel Bacterial Targets for the Treatment of Inflammatory Bowel Disease

January 30, 2018 Microbiome Times

NESS ZIONA, Israel, Jan. 30, 2018 /PRNewswire/ — BiomX Ltd., a microbiome company developing customized phage therapies, today announced that it has exclusively sub-licensed from JSR Corporation a set of bacterial targets for the development and […]

Elanco Announces Global Agreement with Ab E Discovery for New Technology

January 25, 2018 Microbiome Times

Elanco Animal Health, a division of Eli Lilly and Company (NYSE: LLY), is pleased to announce a new global in-licensing agreement with Ab E Discovery to further develop and bring to market an egg antibody […]